Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment
J Dermatolog Treat
.
2022 Sep;33(6):2876-2877.
doi: 10.1080/09546634.2022.2071820.
Epub 2022 May 4.
Authors
Nelson Ugwu
1
,
Shayan Cheraghlou
2
,
Hao Feng
3
,
Jeffrey M Cohen
4
Affiliations
1
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
2
The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
3
Department of Dermatology, University of Connecticut Health Center, Farmington, CT, USA.
4
Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.
PMID:
35509155
DOI:
10.1080/09546634.2022.2071820
No abstract available
Publication types
Letter
MeSH terms
Biological Products* / therapeutic use
Dermatologists
Humans
Practice Patterns, Physicians'
Prescriptions
Psoriasis* / drug therapy
Substances
Biological Products